David received his PhD in Biology and Biotechnology at Worcester Polytechnic Institute, where he investigated relationships between molecular signaling and cellular phenotypes in order to augment regenerative therapies. As a postdoctoral fellow in the Department of Surgery at Northwestern University, he subsequently studied therapeutic modalities to promote wound healing and suppress fibrosis using a combination of cellular and animal models, fostering burgeoning interest and expertise in basic pharmacology and drug repurposing.

David brings broad experience in regenerative medicine and humble fascination with the biomedical sciences to his role of Project Scientist at Greenstone Biosciences, where he hopes to facilitate the translation of scientific discovery into measurable, clinically significant patient benefit.